Approvals/NMPA/Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅱ)

Approved

化学药品

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅱ)

ASTRAZENECA AB🇨🇳 National Medical Products Administration

Approval Id: 8TEKtCfRY8T
Approval Number: 国药准字HJ20230076
Generic Name: 达格列净二甲双胍缓释片(Ⅱ)
Generic Name En: Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅱ)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 达格列净2.5 mg（以C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000 mg
Reg Date: 2023-06-21
Expired Date: 2028-06-20
Company Name: ASTRAZENECA AB
Production Company Name: ASTRAZENECA PHARMACEUTICALS LP
Company Detail Path: /organization/astrazeneca-ab
Production Company Detail Path: /organization/astrazeneca-pharmaceuticals-lp

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 21, 2023

Approval ID

8TEKtCfRY8T

Type

化学药品